RT Journal Article
SR Electronic
T1 Testing & Opening in Augustusburg A Success Story?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.16.21258869
DO 10.1101/2021.06.16.21258869
A1 Marc Diederichs
A1 Timo Mitze
A1 Felix Schulz
A1 Klaus Wälde
YR 2021
UL http://medrxiv.org/content/early/2021/06/22/2021.06.16.21258869.abstract
AB The city of Augustusburg allowed for opening of, inter alia, restaurants and hotels joint with large-scale testing. We evaluate this testing & opening (T&O) experiment by comparing the evolution of case rates in Augustusburg with the evolution in other communities of Saxony. We have access to small-scale SARS-CoV-2 infection data at the community level (” Gemeinde”) instead of the county level (” Landkreis”) usually used for disease surveillance. Despite data challenges, we conclude that T&O did not lead to any increase in case rates in Augustusburg compared to its control county. When we measure the effect of T&O on cumulative cases, we find a small increase in Augustusburg. This difference almost completely disappears when we control for the effect of higher case rates due to more testing. Generally speaking, T&O worked much better than in comparable projects elsewhere.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no approval/ exemption neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yespublic data